A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference

Minae Niwa, Atsumi Nitta, Hiroyuki Mizoguchi, Yasutomo Ito, Yukihiro Noda, Taku Nagai, Toshitaka Nabeshima

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Drug addiction places an enormous burden on society through its repercussions on crime rate and healthcare. Repeated exposure to drugs of abuse causes cellular adaptations in specific neuronal populations that ultimately can lead to a state of addiction. In the present study, we have identified a novel molecule "shati" from the nucleus accumbens (NAc) of mice treated with methamphetamine (METH) using the PCR-select complementary DNA subtraction method. Moreover, we investigated whether shati is involved in METH-induced hyperlocomotion, sensitization, and conditioned place preference (CPP). METH induced expression of shati mRNA dose dependently via dopamine (DA) receptors. We prepared antibodies against shati and, using them, found shati to be expressed in neuronal cells of the mouse brain. Treatment with the shati antisense oligonucleotide (shati-AS), which significantly inhibited the expression of shati mRNA, enhanced the acute METH response, METH-induced behavioral sensitization, and CPP. Blockage of shati mRNA by shati-AS potentiated the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in synaptosomal and vesicular DA uptake in the midbrain. These results suggest that a novel molecule shati is involved in the development of METH-induced hyperlocomotion, sensitization, and CPP. The functional roles of shati in METH-regulated behavioral alternations are likely to be mediated by its inhibitory effects on the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in DA uptake in the midbrain.

Original languageEnglish
Pages (from-to)7604-7615
Number of pages12
JournalJournal of Neuroscience
Volume27
Issue number28
DOIs
Publication statusPublished - 11-07-2007

Fingerprint

Methamphetamine
Dopamine
Nucleus Accumbens
Antisense Oligonucleotides
Mesencephalon
Messenger RNA
Dopamine Receptors
Street Drugs
Crime
Substance-Related Disorders
Complementary DNA
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Niwa, Minae ; Nitta, Atsumi ; Mizoguchi, Hiroyuki ; Ito, Yasutomo ; Noda, Yukihiro ; Nagai, Taku ; Nabeshima, Toshitaka. / A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. In: Journal of Neuroscience. 2007 ; Vol. 27, No. 28. pp. 7604-7615.
@article{5e7b08beac454e09ad7139eebd66368d,
title = "A novel molecule {"}shati{"} is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference",
abstract = "Drug addiction places an enormous burden on society through its repercussions on crime rate and healthcare. Repeated exposure to drugs of abuse causes cellular adaptations in specific neuronal populations that ultimately can lead to a state of addiction. In the present study, we have identified a novel molecule {"}shati{"} from the nucleus accumbens (NAc) of mice treated with methamphetamine (METH) using the PCR-select complementary DNA subtraction method. Moreover, we investigated whether shati is involved in METH-induced hyperlocomotion, sensitization, and conditioned place preference (CPP). METH induced expression of shati mRNA dose dependently via dopamine (DA) receptors. We prepared antibodies against shati and, using them, found shati to be expressed in neuronal cells of the mouse brain. Treatment with the shati antisense oligonucleotide (shati-AS), which significantly inhibited the expression of shati mRNA, enhanced the acute METH response, METH-induced behavioral sensitization, and CPP. Blockage of shati mRNA by shati-AS potentiated the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in synaptosomal and vesicular DA uptake in the midbrain. These results suggest that a novel molecule shati is involved in the development of METH-induced hyperlocomotion, sensitization, and CPP. The functional roles of shati in METH-regulated behavioral alternations are likely to be mediated by its inhibitory effects on the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in DA uptake in the midbrain.",
author = "Minae Niwa and Atsumi Nitta and Hiroyuki Mizoguchi and Yasutomo Ito and Yukihiro Noda and Taku Nagai and Toshitaka Nabeshima",
year = "2007",
month = "7",
day = "11",
doi = "10.1523/JNEUROSCI.1575-07.2007",
language = "English",
volume = "27",
pages = "7604--7615",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "28",

}

A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. / Niwa, Minae; Nitta, Atsumi; Mizoguchi, Hiroyuki; Ito, Yasutomo; Noda, Yukihiro; Nagai, Taku; Nabeshima, Toshitaka.

In: Journal of Neuroscience, Vol. 27, No. 28, 11.07.2007, p. 7604-7615.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference

AU - Niwa, Minae

AU - Nitta, Atsumi

AU - Mizoguchi, Hiroyuki

AU - Ito, Yasutomo

AU - Noda, Yukihiro

AU - Nagai, Taku

AU - Nabeshima, Toshitaka

PY - 2007/7/11

Y1 - 2007/7/11

N2 - Drug addiction places an enormous burden on society through its repercussions on crime rate and healthcare. Repeated exposure to drugs of abuse causes cellular adaptations in specific neuronal populations that ultimately can lead to a state of addiction. In the present study, we have identified a novel molecule "shati" from the nucleus accumbens (NAc) of mice treated with methamphetamine (METH) using the PCR-select complementary DNA subtraction method. Moreover, we investigated whether shati is involved in METH-induced hyperlocomotion, sensitization, and conditioned place preference (CPP). METH induced expression of shati mRNA dose dependently via dopamine (DA) receptors. We prepared antibodies against shati and, using them, found shati to be expressed in neuronal cells of the mouse brain. Treatment with the shati antisense oligonucleotide (shati-AS), which significantly inhibited the expression of shati mRNA, enhanced the acute METH response, METH-induced behavioral sensitization, and CPP. Blockage of shati mRNA by shati-AS potentiated the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in synaptosomal and vesicular DA uptake in the midbrain. These results suggest that a novel molecule shati is involved in the development of METH-induced hyperlocomotion, sensitization, and CPP. The functional roles of shati in METH-regulated behavioral alternations are likely to be mediated by its inhibitory effects on the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in DA uptake in the midbrain.

AB - Drug addiction places an enormous burden on society through its repercussions on crime rate and healthcare. Repeated exposure to drugs of abuse causes cellular adaptations in specific neuronal populations that ultimately can lead to a state of addiction. In the present study, we have identified a novel molecule "shati" from the nucleus accumbens (NAc) of mice treated with methamphetamine (METH) using the PCR-select complementary DNA subtraction method. Moreover, we investigated whether shati is involved in METH-induced hyperlocomotion, sensitization, and conditioned place preference (CPP). METH induced expression of shati mRNA dose dependently via dopamine (DA) receptors. We prepared antibodies against shati and, using them, found shati to be expressed in neuronal cells of the mouse brain. Treatment with the shati antisense oligonucleotide (shati-AS), which significantly inhibited the expression of shati mRNA, enhanced the acute METH response, METH-induced behavioral sensitization, and CPP. Blockage of shati mRNA by shati-AS potentiated the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in synaptosomal and vesicular DA uptake in the midbrain. These results suggest that a novel molecule shati is involved in the development of METH-induced hyperlocomotion, sensitization, and CPP. The functional roles of shati in METH-regulated behavioral alternations are likely to be mediated by its inhibitory effects on the METH-induced increase of DA overflow in the NAc and the METH-induced decrease in DA uptake in the midbrain.

UR - http://www.scopus.com/inward/record.url?scp=34447544385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447544385&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1575-07.2007

DO - 10.1523/JNEUROSCI.1575-07.2007

M3 - Article

VL - 27

SP - 7604

EP - 7615

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 28

ER -